Literature DB >> 14519230

Postoperative regression of desmoplastic infantile gangliogliomas: report of two cases.

Hideo Takeshima1, Yoshihiro Kawahara, Hirofumi Hirano, So-ichi Obara, Masaki Niiro, Jun-ichi Kuratsu.   

Abstract

OBJECTIVE AND IMPORTANCE: Desmoplastic infantile gangliogliomas (DIGs) are extremely rare tumors that respond well to treatment. However, their biological behavior remains to be clarified. We describe two patients whose DIGs spontaneously regressed after surgery, without adjuvant therapy. CLINICAL
PRESENTATION: A 9-month-old girl presented with left hemiparesis, and a 6-month-old boy presented with increasing head circumference. For both patients, neuroimaging demonstrated a huge cystic tumor that included a solid portion and was widely attached to the dura. Gadolinium-diethylenetriamine penta-acetic acid produced strong enhancement. INTERVENTION: One patient underwent partial and the other subtotal tumor removal. Histologically, both tumors were diagnosed as DIGs. Postoperatively, the residual tumors were monitored without adjuvant therapy, and both regressed in several months.
CONCLUSION: Our experience suggests that DIGs may include a subgroup of tumors with a tendency for spontaneous regression, possibly attributable to the induction of apoptosis.

Entities:  

Mesh:

Year:  2003        PMID: 14519230     DOI: 10.1227/01.neu.0000084165.60662.6d

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  13 in total

1.  Atypical MRI appearance of desmoplastic infantile ganglioglioma.

Authors:  Chandrasekharan Kesavadas; Hemant Sonwalker; Bejoy Thomas; Arun Kumar Gupta; Vishnupuri Venkatraman Radhakrishnan
Journal:  Pediatr Radiol       Date:  2005-05-18

2.  Spontaneous regression of cerebellar astrocytoma after subtotal resection.

Authors:  Paul Steinbok; Ken Poskitt; Glenda Hendson
Journal:  Childs Nerv Syst       Date:  2006-03-16       Impact factor: 1.475

Review 3.  Desmoplastic infantile and non-infantile ganglioglioma. Review of the literature.

Authors:  Miguel Gelabert-Gonzalez; Ramón Serramito-García; Andrea Arcos-Algaba
Journal:  Neurosurg Rev       Date:  2011-01-19       Impact factor: 3.042

4.  Desmoplastic infantile astrocytoma: recurrence with malignant transformation into glioblastoma: a case report.

Authors:  Ji Hoon Phi; Eun Jung Koh; Seung-Ki Kim; Sung-Hye Park; Byung-Kyu Cho; Kyu-Chang Wang
Journal:  Childs Nerv Syst       Date:  2011-09-25       Impact factor: 1.475

5.  Desmoplastic infantile ganglioglioma with late presentation. A clinical, radiological and histopathological analysis.

Authors:  Alfredo E Romero-Rojas; Julio A Diaz-Perez; Alfonso Lozano-Castillo
Journal:  Neuroradiol J       Date:  2013-12-18

6.  Novel suprasellar location of desmoplastic infantile astrocytoma and ganglioglioma: a single institution's experience.

Authors:  Ryan M Naylor; Anton Wohl; Aditya Raghunathan; Laurence J Eckel; Gesina F Keating; David J Daniels
Journal:  J Neurosurg Pediatr       Date:  2018-07-06       Impact factor: 2.375

Review 7.  MR imaging, apparent diffusion coefficient and histopathological features of desmoplastic infantile tumors-own experience and review of the literature.

Authors:  Elżbieta Jurkiewicz; Wiesława Grajkowska; Katarzyna Nowak; Paweł Kowalczyk; Anna Walecka; Bożenna Dembowska-Bagińska
Journal:  Childs Nerv Syst       Date:  2014-11-22       Impact factor: 1.475

8.  Desmoplastic infantile astrocytoma and ganglioglioma: a series of 12 patients treated at a single institution.

Authors:  Alessia Imperato; Pietro Spennato; Federica Mazio; Esperanza Arcas; Onur Ozgural; Lucia Quaglietta; Maria Elena Errico; Giuseppe Cinalli
Journal:  Childs Nerv Syst       Date:  2021-01-28       Impact factor: 1.475

9.  Desmoplastic infantile astrocytoma with benign histological phenotype and multiple intracranial localizations at presentation.

Authors:  E Uro-Coste; G Ssi-Yan-Kai; C Guilbeau-Frugier; S Boetto; A I Bertozzi; A Sevely; K Lolmede; M B Delisle
Journal:  J Neurooncol       Date:  2009-12-11       Impact factor: 4.130

10.  Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes.

Authors:  Matthew Clarke; Alan Mackay; Britta Ismer; Jessica C Pickles; Ruth G Tatevossian; Scott Newman; Tejus A Bale; Iris Stoler; Elisa Izquierdo; Sara Temelso; Diana M Carvalho; Valeria Molinari; Anna Burford; Louise Howell; Alex Virasami; Amy R Fairchild; Aimee Avery; Jane Chalker; Mark Kristiansen; Kelly Haupfear; James D Dalton; Wilda Orisme; Ji Wen; Michael Hubank; Kathreena M Kurian; Catherine Rowe; Mellissa Maybury; Stephen Crosier; Jeffrey Knipstein; Ulrich Schüller; Uwe Kordes; David E Kram; Matija Snuderl; Leslie Bridges; Andrew J Martin; Lawrence J Doey; Safa Al-Sarraj; Christopher Chandler; Bassel Zebian; Claire Cairns; Rachael Natrajan; Jessica K R Boult; Simon P Robinson; Martin Sill; Ira J Dunkel; Stephen W Gilheeney; Marc K Rosenblum; Debbie Hughes; Paula Z Proszek; Tobey J Macdonald; Matthias Preusser; Christine Haberler; Irene Slavc; Roger Packer; Ho-Keung Ng; Shani Caspi; Mara Popović; Barbara Faganel Kotnik; Matthew D Wood; Lissa Baird; Monika Ashok Davare; David A Solomon; Thale Kristin Olsen; Petter Brandal; Michael Farrell; Jane B Cryan; Michael Capra; Michael Karremann; Jens Schittenhelm; Martin U Schuhmann; Martin Ebinger; Winand N M Dinjens; Kornelius Kerl; Simone Hettmer; Torsten Pietsch; Felipe Andreiuolo; Pablo Hernáiz Driever; Andrey Korshunov; Lotte Hiddingh; Barbara C Worst; Dominik Sturm; Marc Zuckermann; Olaf Witt; Tabitha Bloom; Clare Mitchell; Evelina Miele; Giovanna Stefania Colafati; Francesca Diomedi-Camassei; Simon Bailey; Andrew S Moore; Timothy E G Hassall; Stephen P Lowis; Maria Tsoli; Mark J Cowley; David S Ziegler; Matthias A Karajannis; Kristian Aquilina; Darren R Hargrave; Fernando Carceller; Lynley V Marshall; Andreas von Deimling; Christof M Kramm; Stefan M Pfister; Felix Sahm; Suzanne J Baker; Angela Mastronuzzi; Andrea Carai; Maria Vinci; David Capper; Sergey Popov; David W Ellison; Thomas S Jacques; David T W Jones; Chris Jones
Journal:  Cancer Discov       Date:  2020-04-01       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.